In this post, we will lay out what we can expect over the next 12 months with regards to the Parkinson’s-related clinical trials research of new therapies. Here at the SoPD, we are primarily interested in disease modification for Parkinson's. Cell replacement therapies in which dopamine-producing stem cells are transplanted into Parkinson’s disease patients could improve motor symptoms, reducing or eliminating the need for dopaminergic medicines, a study suggests. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson's, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of… The Parkinson’s Disease News Today forums are a place to connect with other patients, share tips and talk about the latest research. ... We are excited to bring you a host of new ways to engage with Parkinson's research at this year's RSN Conference. Research Support Network Conference 2019. Parkinson’s research in 2019. We are delighted to announce the return of the Research Support Network (RSN) Conference - this year at the Cranmore Park Conference & Events Centre outside Birmingham. Cutting out a portion of or removing a gene linked to Parkinson’s disease protects against the formation of toxic protein clumps within brain cells, scientists have found.. 2017 was an incredible year for Parkinson’s research, and there is a lot already in place to suggest that 2018 is going to be just as good (if not better).

Ok, below is a non-exhaustive outline of what we should see in the next 12 months. This discovery has the potential to significantly affect the development of next-generation cell-based therapies, which involve injecting healthy cells into brain regions already affected by the disease. The study, “ Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies,” was published in the Journal of Parkinson’s Disease. Join today! Jan. 27, 2020 — People who develop Parkinson's disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new research.